Diabetes Clinical Trials in Boston

Showing 181-200 of 534 trials

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes

NCT03531021

This study is evaluating how to encourage teens to engage in heart healthy behaviors such as being more active or eating in a healthy way. Teens will be randomly assigned to either the usual care group or the group with education, goal-setting, and lifestyle challenges with teammates.

Type1diabetesCardiovascular Risk Factor

Joslin Diabetes Center45 participantsStarted May 2018

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)

NCT00745342

This 2-year randomized, controlled trial examined the impact of a clinic-based, family teamwork intervention on glycemic control in youth with recently diagnosed type 1 diabetes.

Type 1 Diabetes Mellitus

Joslin Diabetes Center105 participantsStarted Mar 1999

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Intensive Care Program for Youth With Diabetes

NCT00961974

The purpose of this study was to determine the ability of a family-focused, office-based intervention to improve medical and behavioral outcomes for children and adolescents with type 1 diabetes.

Type 1 Diabetes

Joslin Diabetes Center154 participantsStarted Apr 2002

Boston, Massachusetts, United States

Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes

Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)

Intensive Care Program for Youth With Diabetes

Diabetes Trials in Other Cities

Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Fuzzy Logic Automated Insulin Regulation

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Other Conditions in Boston